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Background
HEK 293-6E cells expressing constitutively a truncated
version of EBNA-1 were originally developed at the
NRC-BRI in Montreal, Canada. They already proved to
be excellent tools for transient transfection and subse-
quent high-titer production of recombinant proteins [1].
We substantially improved an existing protocol by intro-
ducing a number of additional or alternative steps dur-
ing and after transfection finally resulting in a high-titer
production protocol suitable for routine manufacturing
of mg to gram quantities of desired proteins.
Experimental Setup
A recombinant antibody construct introduced into an
optimised plasmid vector was used as a model protein
for all experiments [2]. A second plasmid for co-expres-
sion of an eGFP reporter gene was added at 5%, total-
ling 1 mg L-1 of plasmid DNA. Cultivation and
transfection of HEK 293-6E cells was either done using
FreeStyleTM F17 medium (Life Technologies) alone or
in combination with SMIF8 2x (Scharfenberg SZS).
Optimization experiments were performed in either sha-
ker flasks, bench-top bioreactor systems (which could be
operated also in continuous perfusion mode) or the Bio-
Lector® 48-well microbioreactor (m2p-labs). Transfec-
tion rates were monitored by co-expressed eGFP using a
flow cytometer (GuavaEasyCyte) (as well as on-line by
fluorescence measurement in the BioLector) and the
antibody production by biolayer interferometry (Octet®
RED96; Pall fortéBIO). The concentrations of selected
metabolites in the supernatant were measured photome-
trically (GalleryTM, Thermo microgenics).
Results
Various strategies which have been reported to be bene-
ficial for protein production in other cell lines such as
CHO or hybridomas proved to be unsuccessful for HEK
293-6E cells. This includes temperature shifts to either
32 or 34.5 °C (mild hypothermia) [3], moderate (485
mosmol kg-1) or strong (595 mosmol kg-1) increases of
the osmolality in the presence of an osmoprotective
reagent [4] and the use of either DMSO or lithium acet-
ate [5] in various concentrations for an increased mem-
brane permeablity during transfection. All of these
strategies were found to be either negligible or negative
on the final yield of the recombinant protein.
Different to that, the histone deacetylaseinhibitors
(HDACi) butyrate and valproate were confirmed to be
highly beneficial for recombinant protein production
withHEK 293-6E cells. Their impact on recombinant
antibody production was analysed using a BioLector
multi microbioreactor as cultivation system. The success
of transient transfection of was monitored on-line by
measurement of the fluorescence development in the
multiwells as well as offline by taking samples which
were made subject to analysis by flow cytrometry.
Recombinant antibody accumulation was measured at
the end of the experiment seven days post transfection.
First of all, it was revealed that reporter gene expression
and corresponding measurement methods are neither
interchangable nor directly comparable to the expression
of the GOI i.e. the recombinant antibody. Antibodies
were found at comparable, significantly increased yields
using either butyrate or valproate (peaking at 3.75 mM,
respectively). No further increase was observed when
supplementing both HDAC inhibitors simultaneously.
All protein hydrolysates tested did completely or dras-
tically inhibit the transfectability of HEK 293-6E cells
(Figure 1A). On the other hand, supplementation with
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(Figure 1B) and substantially higher recombinant protein
concentrations (Figure 1C). The cease of cell prolifera-
tion 96 hours post transfection was a result of sodium
valproate supplementation. Accordingly, no nutrient
limitations or inhibitory accumulations of metabolic
byproducts were detected. Tryptone N1, manufactured
from casein (Organotechnie), completely inhibited tran-
sient transfection of cells but, when supplemented 24 or
48 hrs post transfection at a concentration of 5 g L-1,
increased recombinant antibody production. Similar
results were obtained using different peptones (HyPep
1510, Sheff-Vax, Sheff-CHO, all from Kerry) with HyPep
1510 showing the lowest inhibitory effect during trans-
fection and Sheff-Vax providing best productivity at 5 g
L-1. A further increase in productivity was achieved by
blending tryptone N1 with Sheff-Vax (at 2.5 g L-1,
respectively) which more than doubled the recombinant
protein yield.
Correspondingly, the original transfection and protein
production protocol was improved step by step by
introducing alternative or additional steps of media sup-
plementation and prolonging the cultivation process.
Details of the resulting protocol are listed in Table 1.
Conclusions
Similar to the effect on many other cell lines both sodium
butyrate and valproate substantially increase recombinant
protein productivity of HEK 293-6E cells. However, cells
do also respond with a reduced growth and finally a
decline of viability which suggests a careful adjustment of
both the concentration and the moment for HDACi sup-
plementation. Combinations of both reagents did not
reveal any cummulative effect. Thus, valproate was
selected in order to minimise costs. Protein hydrolysates
severely interfere with the process of cationic polymer-
mediated transient transfection. However, when supple-
mented at a later stage, selected formulations ensure
improved cell-specific recombinant protein productivity
combined with a higher volumetric yield. On the contrary,
many successful strategies reported for the cultivation of
Figure 1 Influence of protein hydrolysates on the transient transfection process and subsequent recombinant antibody production.
Experiments for expression kinetics were performed in triplicate in 125 mL shake flasks with a final filling volume of 50 mL after doubling 48 hrs
post transfection. This was followed by further feeding steps as indicated in Table 1.
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CHO cells proved to be unsuitable for HEK 293-6E. In
addition, this cell line is also behaving quite different com-
pared to other HEK 293 cell lines such as HEK 293 EBNA
(formerly available from Life Technologies). By applying
an improved transfection protocol the resulting final con-
centrations of recombinant antibodies could be increased
by a factor of 4 to 5 and the yield based on the amount of
used plasmid DNA by a factor 8 to 10.
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Table 1. Schedule for transient transfection of HEK 293-6E cells and subsequent feeding
Original transfection protocol Improved standard transfection protocol
- 48 hrs Cell seed at 5·105 mL-1 or ↓
- 24 hrs Cell seed at 1·106 mL-1 - 24-2 hrs Cell seed at 1-2·106 mL-1
0 hrs PEI-mediated transfection 0 hrs Cationicpolymer-mediated transfection
24-48 hrs Tryptone feed (0.5% TN1)
48 hrs Harvest of intracellular proteins or 48 hrs Hydrolysates (0.5%) + volume doubling
72 hrs Glucose feed (4.5 g L-1)
96 hrs Sodium valproate feed (3.75 mmol L-1)
120 hrs Harvest of extracellular proteins
144 hrs or
168 hrs or
192 hrs Harvest of extracellular proteins
Antibody yields in the range of 130 to 150 mg L-1 Antibody yields in the range of 500 to 800 mg L-1
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